Kenichiro Arakawa

发表

Serum deoxyribonuclease I activity can be a useful diagnostic marker for the early diagnosis of unstable angina pectoris or non-ST-segment elevation myocardial infarction.

T. Yasuda, K. Kajinami, M. Ueki, 2012, Journal of cardiology.

Determinants of Plasma Renin Activity

T. Ishizuka, J. Suzuki, T. Konoshita, 2014, Medicine.

Association of Gln222Arg polymorphism in the deoxyribonuclease I (DNase I) gene with myocardial infarction in Japanese patients.

T. Yasuda, K. Kishi, I. Miyamori, 2006, European heart journal.

Serum deoxyribonuclease I activity can be used as a novel marker of transient myocardial ischaemia: results in vasospastic angina pectoris induced by provocation test.

T. Yasuda, I. Miyamori, K. Kajinami, 2007, European heart journal.

Effect of postprandial hyperglycaemia on coronary flow reserve in patients with impaired glucose tolerance and type 2 diabetes mellitus

H. Tada, T. Morishita, K. Kaseno, 2015, Diabetes & vascular disease research.

Predictive Utility of the Changes in Matrix Metalloproteinase‐2 in the Early Phase for Left Ventricular Reverse Remodeling After an Acute Myocardial Infarction

H. Tada, T. Morishita, K. Kaseno, 2015, Journal of the American Heart Association.

Levels of serum deoxyribonuclease I activity on admission in patients with acute myocardial infarction can be useful in predicting left ventricular enlargement due to remodeling.

T. Yasuda, M. Kurabayashi, S. Oshima, 2009, Journal of cardiology.

Abnormal myocardial energy-production state in mitochondrial cardiomyopathy and acute response to L-arginine infusion. C-11 acetate kinetics revealed by positron emission tomography.

H. Okazawa, T. Kudo, I. Miyamori, 2010, Circulation journal : official journal of the Japanese Circulation Society.

Mitochondrial Cardiomyopathy and Usage of l-Arginine

H. Okazawa, H. Tada, M. Ikawa, 2017 .

A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types calcium channel blockers Running title: Anti-albuminuric effects among 4 types of CaCB

I. Miyamori, I. Inoki, T. Konoshita, 2013 .

Effects of Combination Therapy With Olmesartan and Azelnidipine on Serum Osteoprotegerin in Patients With Hypertension

H. Tada, T. Morishita, N. Amaya, 2014, Journal of cardiovascular pharmacology and therapeutics.

Blue toe in a male with cholesterol embolisation syndrome.

T. Ishizuka, T. Konoshita, Y. Makino, 2014, Clinical medicine.

A patient with wegener granulomatosis and intraventricular hemorrhage.

M. Kishimoto, Kenichiro Arakawa, 2003, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Amniotic Fluid Embolism Triggered By Hypertensive Crisis Due to Undiagnosed Pheochromocytoma in a Pregnant Subject With Neurofibromatosis Type 1

K. Nishijima, H. Tada, Y. Yoshida, 2015 .

[A case of cutaneous tuberculosis under steroid & immunosuppressant therapy for dermatomyositis].

Y. Totani, T. Ishizaki, S. Ameshima, 2002, Kekkaku : [Tuberculosis].

Synergy of aldosterone and high salt induces vascular smooth muscle hypertrophy through up-regulation of NOX1

C. Yabe-Nishimura, T. Yasuda, I. Miyamori, 2008, The Journal of Steroid Biochemistry and Molecular Biology.

Serum deoxyribonuclease I activity can be used as a sensitive marker for detection of transient myocardial ischaemia induced by percutaneous coronary intervention.

T. Yasuda, K. Kishi, I. Miyamori, 2005, European heart journal.

First survey of the three gene polymorphisms (PON1 Q192R, eNOS E298D and eNOS C‐786T) potentially associated with coronary artery spasm in African populations and comparison with worldwide data

T. Yasuda, Y. Koda, H. Takeshita, 2011, Cell biochemistry and function.

A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers.

I. Miyamori, I. Inoki, T. Konoshita, 2013, International journal of cardiology.

A new-generation N/L-type calcium channel blocker leads to less activation of the renin–angiotensin system compared with conventional L type calcium channel blocker

I. Miyamori, I. Inoki, T. Konoshita, 2010, Journal of hypertension.

Evaluation of Systemic Redox States in Patients Carrying the MELAS A3243G Mutation in Mitochondrial DNA

M. Ikawa, M. Yoneda, M. Kuriyama, 2012, European Neurology.

PET imaging of redox and energy states in stroke-like episodes of MELAS.

Y. Fujibayashi, H. Okazawa, T. Kudo, 2009, Mitochondrion.

Diagnostic Use of Serum Deoxyribonuclease I Activity as a Novel Early-Phase Marker in Acute Myocardial Infarction

T. Yasuda, K. Kishi, I. Miyamori, 2004, Circulation.

Reverse blood flow-glucose metabolism mismatch indicates preserved oxygen metabolism in patients with revascularised myocardial infarction

H. Okazawa, T. Kudo, H. Tada, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Genetic variant of the renin-angiotensin system and prevalence of type 2 diabetes mellitus: a modest but significant effect of aldosterone synthase

T. Ishizuka, J. Suzuki, T. Konoshita, 2014, Acta Diabetologica.

Evaluation of respiratory chain failure in mitochondrial cardiomyopathy by assessments of 99mTc-MIBI washout and 123I-BMIPP/99mTc-MIBI mismatch.

T. Tsuchida, I. Miyamori, Masashi Tanaka, 2007, Mitochondrion.

In vivo functional brain imaging and a therapeutic trial of L-arginine in MELAS patients.

Y. Fujibayashi, H. Okazawa, T. Kudo, 2012, Biochimica et biophysica acta.

Angiokeratomas in Fabry disease.

T. Onoe, T. Konoshita, Y. Makino, 2013, American Journal of the Medical Sciences.

Serum deoxyribonuclease I activity can be used as a novel marker of transient myocardial ischaemia: results in vasospastic angina pectoris induced by provocation test.

K. Kajinami, H. Takeshita, Y. Kominato, 2007, European heart journal.

Serum deoxyribonuclease I activity can be used as a sensitive marker for detection of transient myocardial ischaemia induced by percutaneous coronary intervention.

T. Yasuda, K. Kishi, I. Miyamori, 2005, European heart journal.